What is your approach for choosing between Imetelstat and Luspatercept in managing MDS related anemia?
1
1 Answers
Mednet Member
Hematology · BIDMC
In the past 18 months, between the COMMANDS trial looking at Luspatercept in expanded indications beyond just patients with MDS-RS and the IMerge trial looking at the use of Imetelstat in patients with low-risk MDS, we now have many more options for these patients.
The COMMANDS trial looked at Luspat...